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ligand for RON was identified as macrophage stimulating Activation of RON causes cell dissociation, motility and protein (MSP) (17-19), also known as hepatocyte growth invasion of extracellular matrices, suggesting that RON factor-like protein (20) . The mature RON is a 180 kDa might be involved in tumor metastasis. We report here the heterodimeric protein composed of a 40 kDa extracellular α cloning of a novel splice variant of RON in human colorectal chain and a 145 kDa transmembrane β chain (15, 18) . Both carcinoma cell line HT-29. This RON variant is first chains are derived from proteolytic conversion of a 180 kDa produced as a single chain precursor with a molecular RON precursor (15) . RON is expressed in several epithelial mass of 160 kDa. Proteolytic cleavage results in a 40 kDa tissues (19,21), in certain types of tissue macrophages (22,23) α chain and a short form of the β chain with a molecular and in some erythroleukemia cell lines (24) . The roles of RON mass of 125 kDa. The altered receptor is synthesized from in cell transformation and tumor progression are largely a transcript differing from the full-length RON mRNA by unknown. Nevertheless, RON is overexpressed in many an in-frame deletion of 109 amino acids in the extracellular primary breast carcinomas (25) . Point mutations in the tyrosine domain of the RON β chain. The consequence of the kinase domain are able to release the oncogenic potential of deletion is constitutive activation of the protein with autothe RON receptor (26) . Moreover, RON activation causes phosphorylation. Expression of the RON variant in colon invasive growth and motility of certain epithelial tumor cells epithelial CoTr cells results in increased cell migration and (27, 28) . Recently, a splicing variant of RON was identified in invasion of extracellular matrices. These data suggest that a human stomach cancer cell line KATO-III (29). This molecule generation of the activated splice variant of RON may is encoded by a transcript differing from the full-length RON contribute to the invasive phenotype of human colorectal mRNA by an in-flame deletion of 49 amino acids in the β carcinomas in vivo.
chain extracellular domain (29). Expression of this RON variant promotes invasive growth of transfected epithelial cells (29). Considering these facts, it is suggested that RON might be Introduction involved in the progression of certain epithelial malignancies, Receptor-type protein tyrosine kinases, such as those for EGF, particularly at the stage of tumor metastasis (25, 28, 29) . FGF and NGF, are a group of cell surface proteins that play
We report here the cloning of a novel splice variant of RON a critical role in cell growth, differentiation and movement (RON∆p160) from the human colorectal carcinoma cell line (1, 2) . Constitutive activation of receptor tyrosine kinases has HT-29. The function of RON∆p160 in regulating cell migration been implicated in the progression of certain types of human and matrix invasion was also studied. We found that malignancies, such as tumors derived from breast and kidney RON∆p160 is constitutively activated in HT-29 cells and in tissues (3, 4) . It has been shown that receptor tyrosine kinases transfected CoTr colon epithelial cells. CoTr cells expressing can be activated by a variety of mechanisms, including RON∆p160 showed increased cell migration and matrix invasmutation, deletion, gene rearrangement and alternative mRNA ive activity. These data suggest that RON∆p160 might play splicing (5) . A typical example is the MET proto-oncogene, an important role in vivo in promoting the invasive phenotype which encodes the receptor for hepatocyte growth factor/ of colorectal carcinoma cells. scatter factor (6, 7) . Constitutive activation of MET has been found by gene rearrangement, which generates a hybrid protein Materials and methods in which the MET kinase domain is fused with the sequence Immunoprecipitation and western blotting Cells (3-5ϫ10 6 per sample) were lysed with 200 µl of lysis buffer (50 mM Tris, pH 7.4, 0.5% Triton X-100, 0.5% NP-40, 150 mM NaCl, 2 mM EDTA, 100 mM vanadate, 5 µg/ml leupeptin, 5 µg/ml aprotinin and 10 µg/ml soybean trypsin inhibitor). Cellular proteins were incubated overnight at 4°C with 1 µg of mAb ID2 coupled to protein G-Sepharose beads (Amersham Pharmacia Biotech, Piscataway, NJ). Samples were separated on an 8% polyacrylamide gel under reducing or non-reducing conditions and transferred to Immobilon-P membrane (Millipore, Bedford, MA). Western blotting was performed using rabbit IgG to RON or mAb 4G10 to phosphotyrosine, followed by goat antimouse or rabbit IgG conjugated with horseradish peroxidase (Roche). The Fig. 1 
control. After immunoprecipitation of RON and RON∆p160
Cell migration assay with mAb ID2, the phosphorylation assay was performed by
The migration assay was performed as previously described (18). Briefly, western blotting using mAb 4G10 to phosphotyrosine. The tion moderately increased p125 phosphorylation. These results
Matrigel invasion assay
suggest that RON and its variant form RON∆160 are constitu-
The assay was performed as described (30) illustrates the procedures used in cloning and constructing the was ligated into the pDR2 mammalian expression vector (Clontech) and then transfected into CoTr cells. RON∆p160 expression was determined by western blotting. The results are shown in Figure 6A . In RON∆p160 cDNA-transfected cells two bands with molecular masses of 160 and 125 kDa, respectively, were observed. The 160 kDa band is the uncleaved pro-RON∆p160 protein. The 125 kDa band is the RON∆ β chain. These data suggest that RON∆p160 is first synthesized as a single chain precursor and then proteolytically cleaved into the two chain form. The α chain of RON∆p160 was not The data in Figure 6B show the results from tyrosine stimulation slightly increased phosphorylation of the RON∆ β chain. These results are consistent with those shown in Figure  2 , indicating that deletion of 109 amino acid residues in the full-length RON∆p160 cDNA. In RT-PCR mRNAs from Colo-201 cells were used as controls, because they expressed the RON β chain causes autophosphorylation of the protein. The results also provide evidence that RON∆p160 is located on mature RON protein only. DNA sequence analysis showed that no deletion or mutation was observed in fragments II and the cell surface and is capable of interacting with MSP. III (data not shown), however, in fragment I two PCR products
Induction of cell migration and matrix invasion by RON∆p160 were identified in HT-29 cells (Figure 4). One product is the
To study the function of RON∆p160, we established CoTr cell 2.5 kb fragment, which represents the normal size of the lines expressing this RON variant. These cells, together with amplified product. The other product is a 2.2 kb fragment that CoTr cells transfected with wild-type RON, were used in a is shorter than the expected size. Both fragments were isolated, cell migration assay. The results are shown in Figure 7A . CoTr subcloned into the pGEM-T vector and subsequently cells transfected with the pDR2 vector alone did not migrate sequenced. In comparison with the 2.5 kb sequence it is clear even in the presence of MSP. These data are consistent with that the 2.2 kb fragment lacked 327 nt from T1748 to G2074.
the results shown in Figures 1 and 2 , which indicate that CoTr This deletion results in an in-frame deletion of 109 amino cells do not express RON. In contrast, CoTr cells expressing acids in the extracellular domain of the β chain. Figure 5 wild-type RON responded to MSP. Cells migrated in a MSP shows the cDNA sequences obtained from these two fragments.
concentration-dependent manner. Maximal cell migration was The location of the deleted nucleotides and their corresponding observed when 2.5 nM MSP was added. Interestingly, expresamino acids occurring in the 2. The matrix invasiveness of CoTr cells expressing wild-type RON or RON∆p160 was also studied in an invasion assay. The results are shown in Figure 7B . Activation of wild-type RON by MSP caused CoTr cells to invade the Matrigel. CoTr cells expressing RON∆p160 also showed increased invasive activity. The addition of MSP further increased the invasiveness of RON∆p160-expressing cells. These results are consistent with the data shown in Figure 7A , indicating the effect of constitutive activation of RON∆p160 in transfected cells. Taken together, these results suggest that RON∆p160 expression is conversion of the RON precursor and its transportation (29). RON∆p160 is the product of a transcript differing from
The protein did not undergo proteolytic conversion and the full-length RON mRNA. As described for the RT-PCR remained in the cytoplasm (29). The reason(s) that this particuexperiments, two PCR fragments of 2.5 and 2.2 kb could be lar RON variant was not cleaved is unknown. One possible amplified from mRNAs derived from HT-29 cells, using explanation is that deletion of these 49 amino acids fundamentprimers covering nt -183 to 2315. DNA sequence analysis ally changes three-dimensional structures of the pro-RON confirmed that a deletion of 327 nt occurred in the 2.2 kb variant, which results in 'masking' of the cleavage site, fragment. Thus, the predicted RON variant has an in-frame however, in our case the cleavage site is still exposed on the deletion of 109 amino acids in the extracellular domain of the surface of the pro-RON∆p160 molecule despite deletion of a RON β chain, which will have a molecular mass of 125 large number of amino acids. Furthermore, RON∆p160 is kDa. The results of our western blot analysis confirmed this capable of interacting with the ligand MSP, as is evident from prediction. The β chain of RON∆p160 displayed a molecular its further phosphorylation upon MSP stimulation. mass of 125 kDa, which matches the predicted size of As observed, RON∆p160 is constitutively active in TH-29 the protein.
cells and in transfected CoTr cells. Activation could be Deletion of large numbers of amino acids within a protein further increased by MSP, as is evident from the tyrosine is usually the result of mRNA splicing (31). The existence of phosphorylation of RON∆p160 in transfected CoTr cells. splicing variants has been found in a variety of oncoproteins, Although we did not study the mechanisms of how the deletion such as HER2, Smad2 and MET (11, 32, 33 ). These splicing products display different biological properties in comparison caused receptor activation, it is worth pointing out that there with the non-spliced proteins (11, 32, 33) . The available informaare three cysteines in the deleted region. Lack of these critical tion on the genomic structures of the human RON gene amino acids creates an uneven number of cysteine residues in (34) prompted us to determine whether production of the the extracellular domain of the RON∆p160 β chain. It has RON∆p160 protein is due to deletion of certain exons in the been shown that the unbalanced number of cysteine residues RON gene. The human RON gene consists of 20 exons and in the extracellular domain of the RON variant results in 19 introns (34). Comparing genomic sequences that encode abnormal formation of intermolecular disulfide bonds (29). the extracellular domain of RON, we found that the 109 amino
The consequence of such abnormal bond formation is oligoacids from Phe574 to Met682 represent two exons of the RON merization of the altered receptor and autophosphorylation gene, exons 5 and 6. Exon 5 contains 161 nt and encodes 54 (29). We think that the same mechanism may apply to the amino acid residues from Phe574 to Arg627. Exon 6 has 166 spontaneous activation of RON∆p160 in HT-29 cells, however, nt and encodes 55 amino acid residues from Pro628 to Met682.
further studies using DNA mutagenesis techniques are needed Deletion of these 109 amino acids results in the direct to reveal whether our hypothesis is valid. connection of Glu573, the last amino acid residue of exon 4, It is clear from our current findings that deletion of 109 with Glu683, the first amino acid residue of exon 7. Currently, amino acid residues located in the extracellular domain of the the mechanism(s) that governs the splicing process of RON RON β chain has a significant impact on receptor function. mRNA in HT-29 cells is unknown. However, because selection Similar results have also been demonstrated in a RON variant of a splicing site depends not only on its own sequence but reported in a previously published paper (29). With spontaneous also on the context around that sequence (31), it is reasonable activation of RON∆p160 the downstream motile-invasive to think that the elimination of exons 5 and 6 is not a random program is induced, and further increased by ligand stimulation. splicing process occurring in HT-29 cells. Our recent data also Moreover, transfected CoTr cells acquire a phenotype characindicate that deletion of these two exons is not related to a terized by the ability to migrate through a membrane and genomic abnormality in the boundary sequences between penetrate an artificial basement membrane in vitro. This introns and exons, because no mutations were found in the property correlates with the metastatic phenotype displayed deleted region and the surrounding sequences (our unpubin vivo by malignant tumors (35,36). Because of the unique lished data).
biological properties of RON∆p160, it will be of interest in The mature two chain form of RON is derived from a single the future to determine such functions of RON∆p160 as cell chain precursor, which is cleaved at the Lys305-Arg-Arg-Argtransforming potential and to study its role in the progression Arg sequence, generating α and β chains linked by a disulfide bond (15) . At present it is not known whether cleavage of of human colorectal carcinoma cells in vivo.
